Amphastar Pharmaceuticals, Inc.

Healthcare · Drug Manufacturers - Specialty & Generic

26.30$ +5.2% vs. previous close Closing price · As of: Sep 24, 2026

Statements

Balance Sheet

Amphastar Pharmaceuticals, Inc. (AMPH) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 1,744 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Amounts Change % Common size %

Last 12 Full history

Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet AMPH
Line item	Q3 16	Q4 16	Q1 17	Q2 17	Q3 17	Q4 17	Q1 18	Q2 18	Q3 18	Q4 18	Q1 19	Q2 19	Q3 19	Q4 19	Q1 20	Q2 20	Q3 20	Q4 20	Q1 21	Q2 21	Q3 21	Q4 21	Q1 22	Q2 22	Q3 22	Q4 22	Q1 23	Q2 23	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26
Total Assets	429	428	436	444	438	455	450	452	481	514	545	601	586	587	573	600	614	631	646	666	652	672	716	724	727	742	774	1,378	1,545	1,513	1,574	1,492	1,545	1,577	1,626	1,615	1,666	1,629	1,648	1,744
Current Assets	190	184	191	194	176	188	174	170	195	220	230	284	269	255	247	267	277	280	300	311	304	318	364	377	384	378	408	385	543	490	555	483	546	534	588	581	639	636	634	631
Cash	67	72	77	83	67	66	55	48	69	86	79	120	86	76	57	89	90	93	102	125	107	126	173	166	157	156	177	151	267	144	201	190	192	152	183	188	217	170	171	224
Cash & Short-Term Investments	67	73	78	83	69	68	57	51	72	89	82	123	98	90	71	103	103	106	118	139	117	137	187	186	187	176	195	168	300	257	290	218	250	222	237	232	279	283	294	290
Receivables	27	27	26	24	24	36	32	41	44	52	55	49	45	45	58	50	52	66	78	68	78	79	73	81	77	89	101	105	119	115	139	132	145	138	145	135	147	144	148	145
Inventory	91	80	78	74	70	64	63	62	65	69	79	99	110	111	108	105	109	97	97	98	100	93	95	99	103	104	104	105	110	106	115	122	130	154	185	192	186	177	170	180
Property, Plant & Equipment	152	153	157	162	173	185	192	198	203	210	215	220	222	234	231	238	246	260	253	280	271	244	243	238	233	238	243	279	–	–	–	–	–	–	–	–	–	–	–	–
Goodwill	4.2	4.0	4.0	4.3	4.4	4.5	4.6	4.4	4.0	4.0	3.9	3.9	3.8	3.6	3.6	3.6	3.8	3.9	3.8	3.8	3.4	3.3	3.3	3.1	2.9	3.1	3.2	3.2	3.1	3.2	3.2	3.1	3.3	3.0	3.2	3.4	3.4	3.4	3.3	3.4
Intangible Assets	48	46	42	42	41	41	40	39	39	38	38	38	37	38	37	37	37	37	36	36	36	36	35	35	34	34	34	622	616	610	604	598	592	588	581	575	569	563	556	563
Total Liabilities	100	98	110	111	107	117	123	131	139	149	164	169	152	159	149	158	163	183	195	199	222	226	237	224	222	213	225	789	949	873	902	778	818	845	875	858	889	840	875	976
Current Liabilities	61	61	73	64	57	67	73	88	97	107	112	101	87	90	83	93	97	112	127	125	98	104	114	104	102	95	106	251	258	225	255	137	159	174	199	176	205	158	164	263
Short-Term Debt	8.5	5.4	5.3	6.2	6.2	6.3	6.1	19	19	18	23	12	13	11	15	16	16	16	16	11	5.1	5.2	5.4	5.4	4.9	6.0	5.2	16	4.2	4.3	4.4	4.2	4.5	7.0	8.0	8.8	8.8	9.6	11	11
Accounts Payable	13	16	19	15	9.6	17	16	22	23	31	34	31	22	25	17	22	23	24	23	28	22	22	24	31	20	21	22	19	32	25	37	32	34	31	53	42	41	33	36	29
Long-Term Debt	34	32	31	40	42	41	40	34	33	31	31	40	38	39	36	35	33	34	32	30	76	75	74	74	74	73	73	488	638	590	594	587	596	602	604	608	609	609	610	610
Shareholders' Equity	328	329	326	333	331	337	327	321	319	332	335	388	389	381	378	398	405	402	406	422	430	446	480	499	505	529	549	589	595	639	672	713	728	732	751	757	777	789	773	768
Retained Earnings	74	71	73	75	75	76	70	67	66	67	68	116	117	116	120	120	124	118	123	131	161	180	205	222	238	272	298	324	373	409	452	490	531	569	594	625	642	667	673	704
Shares Outstanding	48	46	48	48	48	49	47	47	48	49	50	50	50	47	48	47	50	47	50	50	50	50	52	53	53	52	52	53	54	53	53	52	52	52	50	48	48	47	46	44

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?

Balance Sheet

Cookie settings